Radiation recall gastritis secondary to combination of gemcitabine and erlotinib in pancreatic cancer and response to PPI - a case report

BACKGROUND: Radiation recall gastritis is rare but can be induced after concurrent chemoradiation for pancreatic cancer. We report a patient with pancreatic cancer who developed radiation-recall gastritis related to a combination of gemcitabine and erlotinib. CASE PRESENTATION: A 54-year-old female...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Seong Ji, Kim, Hyo Jung, Kim, Jae Seon, Bak, Young-Tae, Kim, Jun Suk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971692/
https://www.ncbi.nlm.nih.gov/pubmed/27484349
http://dx.doi.org/10.1186/s12885-016-2616-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971692/
https://www.ncbi.nlm.nih.gov/pubmed/27484349
http://dx.doi.org/10.1186/s12885-016-2616-3

Ejemplares similares